These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25762480)

  • 21. Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age.
    Fisher CS; Martin-Dunlap T; Ruppel MB; Gao F; Atkins J; Margenthaler JA
    Ann Surg Oncol; 2012 Oct; 19(10):3246-50. PubMed ID: 22833001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database.
    Barry PN; Johnson RR; Harkenrider MM; Freeman AB; Kruse B; Wilson MR; Pan J; Dragun AE
    Am J Med Sci; 2012 Dec; 344(6):452-6. PubMed ID: 22395715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors for contralateral prophylactic mastectomy in breast cancer patients.
    Fu Y; Zhuang Z; Dewing M; Apple S; Chang H
    Int J Clin Exp Pathol; 2015; 8(4):3748-64. PubMed ID: 26097557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer.
    Peralta EA; Ellenhorn JD; Wagman LD; Dagis A; Andersen JS; Chu DZ
    Am J Surg; 2000 Dec; 180(6):439-45. PubMed ID: 11182394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
    Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
    Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.
    Partridge A; Adloff K; Blood E; Dees EC; Kaelin C; Golshan M; Ligibel J; de Moor JS; Weeks J; Emmons K; Winer E
    J Natl Cancer Inst; 2008 Feb; 100(4):243-51. PubMed ID: 18270338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in Unilateral and Contralateral Prophylactic Mastectomy Use in Ductal Carcinoma In Situ of the Breast: Patterns and Predictors.
    Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC; Oseni TO
    Ann Surg Oncol; 2019 Nov; 26(12):3863-3873. PubMed ID: 31325048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.
    Parker PA; Peterson SK; Bedrosian I; Crosby MA; Shen Y; Black DM; Babiera G; Kuerer HM; Ying J; Dong W; Cantor SB; Brewster AM
    Ann Surg; 2016 Jan; 263(1):178-83. PubMed ID: 25822675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
    Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
    Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
    Rosenberg SM; Sepucha K; Ruddy KJ; Tamimi RM; Gelber S; Meyer ME; Schapira L; Come SE; Borges VF; Golshan M; Winer EP; Partridge AH
    Ann Surg Oncol; 2015 Nov; 22(12):3809-15. PubMed ID: 25930247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States.
    Rutter CE; Park HS; Killelea BK; Evans SB
    Ann Surg Oncol; 2015 Jul; 22(7):2378-86. PubMed ID: 25564175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base.
    Pesce CE; Liederbach E; Czechura T; Winchester DJ; Yao K
    J Am Coll Surg; 2014 Jul; 219(1):19-28. PubMed ID: 24862886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
    Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
    J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incremental risk associated with contralateral prophylactic mastectomy and the effect on adjuvant therapy.
    Eck DL; Perdikis G; Rawal B; Bagaria S; McLaughlin SA
    Ann Surg Oncol; 2014 Oct; 21(10):3297-303. PubMed ID: 25047470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy.
    Ager B; Jansen J; Porter D; Phillips KA; Glassey R; ; Butow P
    Breast; 2018 Aug; 40():156-164. PubMed ID: 29857282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contralateral prophylactic mastectomy.
    Rai SS; Mahabir RC; Roberts JW; Song J; Hamid KS; White RR
    Ann Plast Surg; 2011 Sep; 67(3):215-9. PubMed ID: 21508813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center.
    Dragun AE; Pan J; Riley EC; Kruse B; Wilson MR; Rai S; Jain D
    Am J Clin Oncol; 2013 Aug; 36(4):375-80. PubMed ID: 22643566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
    Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
    Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An informed decision? Breast cancer patients and their knowledge about treatment.
    Fagerlin A; Lakhani I; Lantz PM; Janz NK; Morrow M; Schwartz K; Deapen D; Salem B; Liu L; Katz SJ
    Patient Educ Couns; 2006 Dec; 64(1-3):303-12. PubMed ID: 16860523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should the use of contralateral prophylactic mastectomy be increasing as it is?
    Wood WC
    Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.